June, 2016 SMM-145
The Genetically Modified Organisation
To paraphrase Darwin, it is not the strongest nor most intelligent life science company that will survive, it is the one most able to change. Yet many companies find it very difficult to change in ways that preserves the best of the corporate DNA whilst adapting to the changes in our technological, political, economic and social environments. New research in this area sheds light on what constitutes a firm’s DNA, what changes are demanded by the market and how firms make these changes. This work allows senior executives to perform the equivalent of gene therapy on their firms: identifying the genes that are necessary for competitiveness and inserting them into their corporate genome.